Biofourmis has secured $300m in a series D funding round to support expansion of its virtual care platforms, raising the Boston company’s total funding to $445m.
The series D investment, announced on 26 April, is led by growth equity firm General Atlantic
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?